Mostrando 2 resultados de: 2
Filtros aplicados
Subtipo de publicación
Article(2)
Área temáticas
Enfermedades(2)
Problemas sociales y servicios a grupos(2)
Medicina forense; incidencia de enfermedades(1)
Medicina y salud(1)
Año de Publicación
2022(2)
Origen
scopus(2)
Viral Load Status Before Switching to Dolutegravir-Containing Antiretroviral Therapy and Associations With Human Immunodeficiency Virus Treatment Outcomes in Sub-Saharan Africa
ArticleAbstract: Background: Dolutegravir is being rolled out globally as part of preferred antiretroviral therapy (APalabras claves:antiretroviral agents, clinical decision-making, HIV integrase inhibitors, prognosis, Viral loadAutores:Diero L., Edwards J.K., Kasozi C., Kelvin E.A., Lelo P., Matthew L. Romo, Murenzi G., Musick B.S., Nash D., Odhiambo F., Semeere A.S., Sohn A.H., Urassa M., Wools-Kaloustian K.K., Wyka K.Fuentes:scopusReal-world use and outcomes of dolutegravir-containing antiretroviral therapy in HIV and tuberculosis co-infection: a site survey and cohort study in sub-Saharan Africa
ArticleAbstract: Introduction: Dolutegravir is being scaled up globally as part of antiretroviral therapy (ART), butPalabras claves:antiretroviral agents, antitubercular agents, drug interactions, HIV integrase inhibitors, Observational Study, rifampinAutores:Brazier E., Chimbetete C., De Waal R., Diero L., Dzudie A., Ezechi O.C., Fenner L., Kunzekwenyika C., Lelo P., Mahambou-Nsondé D., Matthew L. Romo, Muhairwe J.A., Murenzi G., Muyindike W.R., Nash D., Rafael I., Sekaggya-Wiltshire C., Shah N.S., Tiendrebeogo T., Twizere C., Wools-Kaloustian K.K., Yotebieng M.Fuentes:scopus